Jump to Main Content
- Shi, Shuting, et al. Show all 6 Authors
- Vaccine 2019 v.37 no.24 pp. 3167-3178
- adaptive immunity; aluminum; humans; immune response; oligodeoxyribonucleotides; pathogens; structure-activity relationships; therapeutics; vaccine adjuvants; vaccines
- ... In conjugate, inactivated, recombinant, and toxoid vaccines, adjuvants are extensively and essentially used for enhanced and long-lasting protective immune responses. Depending on the type of diseases and immune responses required, adjuvants with different design strategies are developed. With aluminum salt-based adjuvants as the most used ones in commercial vaccines, other limited adjuvants, e.g. ...